Imagion Biosystems Ltd.ASX: IBX

IBX's IND Application Lodged with FDA for HER2 Phase 2 Trial

Feb 2, 2026 at 3:38 AM UTC · Issued by Imagion Biosystems Ltd.

Imagion Biosystems Ltd has released a press release.

View Attachment